ʻO PNC-27 kahi peptide anti-cancer i manaʻo nui ʻia.
Kāohi ia i ka hoʻopaʻa ʻana ma waena o ka protein suppressor tumor p53 a me kona hooponopono kino HDM-2.
HDM-2, he E3 ubiquitin ligase, paipai i ka ubiquitin mediated degradation ma ka hoʻopaʻa ʻana iā p53.
ʻO nā pūnaewele maʻi maʻi no laila e pale aku i ka ulu ʻana e pili ana a me ka maʻamau apoptosis nā pōʻaiapuni.
Hoʻohālike ka PNC-27 i ka māhele kumu o ka protein p53 (nā ʻakika amino 12-26) iho, e pili ana me kēia HDM-2.
ʻIke ʻia, Loaʻa i ka PNC-27 kahi ʻāpana kūʻokoʻa i waiwai nā ʻakika amino kumu, e kōkua ana i ke komo ʻana o nā membrane cell i makemake nui ʻia.
Kaʻina
H-Pro-Pro-Leu-Ser-Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg
Helu CAS
1159861-00-3
ʻĀpana Molekala
C188H293N53O44S
Kaumaha Molekala
4031.7990
Noiʻi o PNC-27
1.Mechanism of Action and Membrane Disruption
ʻO ka hoʻokuʻu ʻana i kēia paʻa e hiki ai ke hoʻihoʻi piha i ka hana protein p53; ʻO ka hoʻoponopono piha ʻana o nā hana maʻi maʻi maʻi ma kahi pae genetic, ʻO ka hoʻopau ʻana i nā ʻano maʻi āpau ka hopena.
ʻO ka hoʻokuʻu ʻana o ka p53 a laila keʻakeʻa i ka hana ʻana o nā cell cancer, ʻO ka apoptosis pololei kekahi o nā hopena hopena.
Ua nānā ʻia nā haʻawina ma hope i ke ʻano o loko o ka PNC-27 e kāohi ana i nā maʻi maʻi maʻi i loko o nā cell.
Ua hōʻike ʻia ka noiʻi i ka hoʻopau pololei ʻana i ka membrane plasma o ke kanesa – wikiwiki, kokoke ka make hiki ole ke hoohuliia, me ka liʻiliʻi loa a ʻaʻohe hopena i koe ma nā pūnaewele maʻamau.
ʻO ka hoʻopaʻa ʻana iā HDM-2 alakaʻi i ka PNC-27 (ma ka hapa iki) e hoololi i ke ano.
Oligomerization a ua manaʻo ʻia ʻo ka hoʻokumu ʻana i ka pore ka hana hope loa o kēia kaʻina hana.
2.Hoʻopaʻa kikoʻī
ʻO ka ʻike kikoʻī a kiʻekiʻe loa o ka HDM-2 e PNC-27 ka mea e hoʻokō pono ai kēia peptide..
ʻO ka hoʻokuʻu ʻana i ka hana p53 ka pahuhopu mua a me ke kikowaena o ka mīkini holoʻokoʻa.
3.Pepehi koho i na ma'i ma'i ma'i
Hoʻopili paʻa ʻia ka PNC i ka HDM-2 i hōʻike ʻole ʻia ma nā maʻi kanesa, ka hoʻoulu ʻana o ka osmotic imbalance a me ka hemo ʻana o ka membrane.
ʻO kēia ka hopena e alakaʻi ai i ka pehu cell; Loa'a ka make ma'i 'a'ai pololei ma o ka hiki 'ole ke ho'ololi, mīkini wikiwiki.
ʻIke ʻia, Hōʻike nā membrane cell maʻamau i nā ʻāpana liʻiliʻi o kēia HDM-2, no laila, ʻaʻole pili nā cell olakino.
ʻO ka hoʻohaunaele kino o ka membrane cell ponoʻī ka mea e hiki ai i kēia pepehi pololei – ʻO nā ala e hilinaʻi nei i ka p53-mediated intracellular apoptosis hōʻailona ua kaʻawale loa mai kēia kaʻina hana.
Me ka nānā ʻole i ke kūlana o ka gene p53 o ka maʻi kanesa (ʻano ʻāhiu, hoʻololi ʻia, a i ʻole i hoʻohana ʻia), ʻoiai ke ʻike ʻia ka hōʻike HDM-2 ma ka membrane, E hoʻopau pono ʻo PNC-27 iā ia.
Hiki ke hoʻopaʻa ʻia i nā maʻi kanesa, ʻo ka poʻe i hoʻomohala i ke kū'ē i ka chemotherapy maʻamau a me nā ʻano like ʻole o ka radiotherapy; ʻO ka p53 dysfunction ke kumu nui o ia kū'ē.
Ke wehe ʻia nei kahi hoʻolālā lapaʻau hou no nā maʻi maʻi kūʻē i ka mālama ʻana e kēia ʻano hana ʻokoʻa.
COA
HPLC
MS





